Table of Contents
- 1 What are the symptoms of APL?
- 2 What is APL disease?
- 3 What is the survival rate for APL?
- 4 How do I confirm my APL diagnosis?
- 5 Can APL be cured as of 2021?
- 6 When should you suspect APL?
- 7 How many people have APL leukemia?
- 8 How long can you live with APL leukemia?
- 9 How is APL treated?
- 10 What causes APL leukemia?
What are the symptoms of APL?
The symptoms of APL are due to the shortage of normal blood cells. They include fevers, fatigue, loss of appetite, and frequent infections. People with APL are also at an increased risk of bleeding and forming blood clots.
What is APL disease?
Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML) in which cells in the bone marrow that produce blood cells (red cells, white cells and platelets) do not develop and function normally. l.
What is APL treatment?
The most important drugs for treating APL are non-chemo drugs called differentiating agents, like all-trans-retinoic acid (ATRA). Other treatments might include chemotherapy (chemo) and transfusions of platelets or other blood products. Treatment is typically divided into 3 phases: Induction (remission induction)
What is the survival rate for APL?
APL is now considered a highly curable disease, with 2-year event-free survival rates of 75–84\%. Early mortality is common in APL and is frequently related to hemorrhagic complications.
How do I confirm my APL diagnosis?
The diagnosis of APL is based on an evaluation of the clinical presentation, morphology, immunophenotyping, karyotype, RT-PCR, FISH and immunofluorescence with anti-PML monoclonal antibodies. The redundancy of diagnostic tests is beneficial because of the broad and indistinct characterization of the disease.
Can APL be cured?
Acute promyelocytic leukemia (APL) has become a curable disease by all-trans retinoic acid (ATRA)-based induction therapy followed by two or three courses of consolidation chemotherapy. Currently around 90\% of newly diagnosed patients with APL achieve complete remission (CR) and over 70\% of patients are curable.
Can APL be cured as of 2021?
Because of advances in diagnostic techniques and modern treatments, APL is now considered the most curable subtype of AML in adults, with complete remission rates of 90 percent following treatment and cure rates of approximately 80 percent reported in clinical trials.
When should you suspect APL?
Thus, in standard-risk APL, hydroxyurea should be initiated if the WBC count rises to >10 × 109/L, and in high-risk disease, anthracycline chemotherapy during induction should be considered.
What leukemia is treated with vitamin A?
ATRA is a form of vitamin A that is typically part of the initial (induction) treatment of APL. It is given either along with chemo, or along with arsenic trioxide for the initial treatment of APL.
How many people have APL leukemia?
Acute promyelocytic leukemia accounts for about 10 percent of acute myeloid leukemia cases. Acute promyelocytic leukemia occurs in approximately 1 in 250,000 people in the United States.
How long can you live with APL leukemia?
Currently large cohort of patients enjoys disease-free survival of 5 years or longer. However, a disease-free status is not synonymous with a life free of physical and psychological health related to the cancer and/or its treatment.
What does APL stand for in insurance?
APL stands for Automatic Premium Loan (Insurance Term) Suggest new definition. This definition appears frequently and is found in the following Acronym Finder categories: Business, finance, etc.
How is APL treated?
Induction. The most important drug in the initial treatment of APL is all-trans-retinoic acid (ATRA). This is usually combined with one of these: Arsenic trioxide (ATO), another non-chemo drug. For some people at higher risk of APL coming back after treatment, the targeted drug gemtuzumab ozogamicin (Mylotarg) might be added as well.
What causes APL leukemia?
APL is due to a translocation (an exchange of chromosome material) between chromosomes 15 and 17 which is symbolized t(15;17). This translocation is not a mere marker of APL. It is the cause of APL. APL was first recognized as a distinct disease entity in 1957. It accounts for 5-10\% of cases of acute myeloid leukemia (AML).